EPPIC GLOBAL Presents
Entrepreneur Spotlight

Pre-Clinical Development of a Humanized Anti-CD47 Antibody
Speaker: Ravi Majeti MD, PhD

Dr. Majeti is co-founder of \’Forty Seven, Inc.\’

Ravi Majeti MD, PhD
Associate Professor of Medicine, Division of Hematology
Cancer Institute
Institute for Stem Cell Biology and Regenerative Medicine

Dr. Ravi Majeti\’s illustrious bio can be found at:
https://med.stanford.edu/profiles/majetilab/ravindra-majeti/

When: Tuesday, Aug 30, 2016

6pm – 7pm Networking mixer

7pm – 8:30pm Spotlight Speaker Presentation followed by Q&A

Where: Offices of Shepherd Mullin, 379 Lytton Ave, Palo Alto

Registration is complimentary. Please use this link to register at the earliest and reserve your spot!
https://www.123signup.com/register?id=nzhgh